New pharmacologic aspects of CS-866, the newest angiotensin II receptor antagonist (Q34239838)

31 July 2017

1 reference

title

New pharmacologic aspects of CS-866, the newest angiotensin II receptor antagonist (English)

1 reference

31 July 2017

H Koike

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

American Journal of Cardiology

31 July 2017

published in

1 reference

31 July 2017

volume

87

1 reference

31 July 2017

issue

8A

1 reference

31 July 2017

page(s)

33C-36C

1 reference

Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compound

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Angiotensin receptors and their antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Role of angiotensin II in diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901540-5

10.1016/S0002-9149(01)01540-5

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference